Advanced Functional Materials,
Journal Year:
2019,
Volume and Issue:
29(50)
Published: Oct. 7, 2019
Abstract
Fe‐based
Fenton
agents
can
generate
highly
reactive
and
toxic
hydroxyl
radicals
(·OH)
in
the
tumor
microenvironment
(TME)
for
chemodynamic
therapy
(CDT)
with
high
specificity.
However,
strict
condition
(lower
pH
environment:
3–4)
of
efficient
reaction
limits
its
practical
application
clinic.
Development
new
CDT
more
suitable
TME
is
significant
challenging.
A
Cu(I)‐based
agent,
copper(I)
phosphide
nanocrystals
(CP
NCs),
which
adaptable
to
value
than
agents,
thereby
producing
·OH
trigger
apoptosis
cancer
cells,
prepared.
Moreover,
excess
glutathione
(GSH)
reduce
Cu(II)
produced
by
a
Fenton‐like
Cu(I),
further
increasing
generation
rate
relieving
antioxidant
ability.
Furthermore,
owing
their
strong
absorption
NIR
II
region,
CP
NCs
exhibit
an
excellent
photothermal
conversion
effect,
improve
reaction.
What
more,
act
as
situ
self‐generation
magnetic
resonance
imaging
(MRI)
paramagnetic
response
H
2
O
TME.
These
properties
may
open
up
exploration
copper‐based
materials
clinical
imaging‐guided
synergetic
treatment.
Angewandte Chemie International Edition,
Journal Year:
2021,
Volume and Issue:
60(17), P. 9480 - 9488
Published: Feb. 6, 2021
Abstract
The
single‐atom
enzyme
(SAE)
is
a
novel
type
of
nanozyme
that
exhibits
extraordinary
catalytic
activity.
Here,
we
constructed
PEGylated
manganese‐based
SAE
(Mn/PSAE)
by
coordination
manganese
to
nitrogen
atoms
in
hollow
zeolitic
imidazolate
frameworks.
Mn/PSAE
catalyzes
the
conversion
cellular
H
2
O
.
OH
through
Fenton‐like
reaction;
it
also
promotes
decomposition
and
continuously
cytotoxic
−
via
oxidase‐like
activity
more
pronounced
weak
acidic
tumor
environment;
therefore,
these
cascade
reactions
enable
sufficient
generation
reactive
oxygen
species
(ROS)
effectively
kill
cells.
prominent
photothermal
property
amorphous
carbon
can
be
utilized
for
therapy.
Hence,
significant
therapeutic
efficacy
microenvironment
stimulated
multiple
ROS
Nature Communications,
Journal Year:
2021,
Volume and Issue:
12(1)
Published: April 13, 2021
Reactive
oxygen
species
(ROS)
are
generated
and
consumed
in
living
organism
for
normal
metabolism.
Paradoxically,
the
overproduction
and/or
mismanagement
of
ROS
have
been
involved
pathogenesis
progression
various
human
diseases.
Here,
we
reported
a
two-dimensional
(2D)
vanadium
carbide
(V2C)
MXene
nanoenzyme
(MXenzyme)
that
can
mimic
up
to
six
naturally-occurring
enzymes,
including
superoxide
dismutase
(SOD),
catalase
(CAT),
peroxidase
(POD),
glutathione
(GPx),
thiol
(TPx)
haloperoxidase
(HPO).
Based
on
these
enzyme-mimicking
properties,
constructed
2D
V2C
MXenzyme
not
only
possesses
high
biocompatibility
but
also
exhibits
robust
vitro
cytoprotection
against
oxidative
stress.
Importantly,
rebuilds
redox
homeostasis
without
perturbing
endogenous
antioxidant
status
relieves
ROS-induced
damage
with
benign
vivo
therapeutic
effects,
as
demonstrated
both
inflammation
neurodegeneration
animal
models.
These
findings
open
an
avenue
enable
use
remedial
nanoplatform
treat
ROS-mediated
inflammatory
neurodegenerative
Advanced Materials,
Journal Year:
2021,
Volume and Issue:
33(48)
Published: Sept. 27, 2021
Chemodynamic
therapy
(CDT)
uses
the
tumor
microenvironment-assisted
intratumoral
Fenton
reaction
for
generating
highly
toxic
hydroxyl
free
radicals
(•OH)
to
achieve
selective
treatment.
However,
limited
efficiency
restricts
therapeutic
efficacy
of
CDT.
Recent
years
have
witnessed
impressive
development
various
strategies
increase
reaction.
The
introduction
these
reinforcement
can
dramatically
improve
treatment
CDT
and
further
promote
enhanced
(ECDT)-based
multimodal
anticancer
treatments.
In
this
review,
authors
systematically
introduce
strategies,
from
their
basic
working
principles,
mechanisms
representative
clinical
applications.
Then,
ECDT-based
is
discussed,
including
how
integrate
emerging
accelerating
therapy,
as
well
synergistic
ECDT
other
methods.
Eventually,
future
direction
challenges
therapies
are
elaborated,
highlighting
key
scientific
problems
unsolved
technical
bottlenecks
facilitate
translation.
Advanced Functional Materials,
Journal Year:
2021,
Volume and Issue:
31(22)
Published: March 8, 2021
Abstract
Triggered
by
the
endogenous
chemical
energy
in
tumor
microenvironment
(TME),
chemodynamic
therapy
(CDT)
as
an
emerging
non‐exogenous
stimulant
therapeutic
modality
has
received
increasing
attention
recent
years.
The
agents
can
convert
internal
hydrogen
peroxide
(H
2
O
)
into
lethal
reactive
oxygen
species
(ROS)
hydroxyl
radicals
(
•
OH)
for
oncotherapy.
Compared
with
other
modalities,
CDT
possesses
many
notable
advantages,
such
tumor‐specific,
highly
selective,
fewer
systemic
side
effects,
and
no
need
external
stimulation.
Nevertheless,
mild
acid
pH,
low
H
content,
overexpressed
reducing
substance
TME
severely
suppressed
efficiency.
With
rapid
development
of
nanotechnology,
some
kinds
nanomaterials
have
been
utilized
improved
In
particular,
excellent
photo‐,
ultrasound‐,
magnetic‐,
stimuli‐response
properties
make
it
possible
combination
cancer
shown
superior
anti‐cancer
activity
than
monotherapies.
Therefore,
is
necessary
to
summarize
application
nanomaterial‐based
therapy.
this
review,
various
nanomaterials‐based
nanoplatforms
its
combinational
therapies
are
summarized
discussed,
aiming
provide
inspiration
design
better‐quality
promote
lay
foundation
future
conversion
clinical
applications.
Advanced Materials,
Journal Year:
2020,
Volume and Issue:
32(8)
Published: Jan. 13, 2020
The
intrinsic
deficiencies
of
nanoparticle-initiated
catalysis
for
biomedical
applications
promote
the
fast
development
alternative
versatile
theranostic
modalities.
catalytic
performance
and
selectivity
are
critical
issues
that
challenging
to
be
augmented
optimized
in
biological
conditions.
Single-atom
catalysts
(SACs)
featuring
atomically
dispersed
single
metal
atoms
have
emerged
as
one
most
explored
biomedicine
recently
due
their
preeminent
activity
superior
distinct
from
nanosized
counterparts.
Herein,
an
overview
pivotal
significance
SACs
some
underlying
need
addressed
is
provided,
with
a
specific
focus
on
applications.
Their
fabrication
strategies,
surface
engineering,
structural
characterizations
discussed
briefly.
In
particular,
triggering
representative
reactions
providing
fundamentals
use
discussed.
A
sequence
paradigms
summarized
successful
construction
varied
(e.g.,
cancer
treatment,
wound
disinfection,
biosensing,
oxidative-stress
cytoprotection)
emphasis
uncovering
mechanisms
understanding
structure–performance
relationships.
Finally,
opportunities
challenges
faced
future
SACs-triggered
outlooked.
Bioactive Materials,
Journal Year:
2021,
Volume and Issue:
6(12), P. 4389 - 4401
Published: April 30, 2021
Nanozymes
have
become
a
new
generation
of
antibiotics
with
exciting
broad-spectrum
antibacterial
properties
and
negligible
biological
toxicity.
However,
their
inherent
low
catalytic
activity
limits
properties.
Herein,
Cu
single-atom
sites/N
doped
porous
carbon
(Cu
SASs/NPC)
is
successfully
constructed
for
photothermal-catalytic
treatment
by
pyrolysis-etching-adsorption-pyrolysis
(PEAP)
strategy.
SASs/NPC
stronger
peroxidase-like
activity,
glutathione
(GSH)-depleting
function,
photothermal
property
compared
non-Cu-doped
NPC,
indicating
that
doping
significantly
improves
the
performance
nanozymes.
can
effectively
induce
in
presence
H
Angewandte Chemie International Edition,
Journal Year:
2020,
Volume and Issue:
59(38), P. 16381 - 16384
Published: June 2, 2020
Abstract
Despite
the
widespread
applications
of
manganese
oxide
nanomaterials
(MONs)
in
biomedicine,
intrinsic
immunogenicity
MONs
is
still
unclear.
MnO
x
nanospikes
(NSs)
as
tumor
microenvironment
(TME)‐responsive
nanoadjuvants
and
immunogenic
cell
death
(ICD)
drugs
are
proposed
for
cancer
nanovaccine‐based
immunotherapy.
NSs
with
large
mesoporous
structures
show
ultrahigh
loading
efficiencies
ovalbumin
fragment.
The
combination
ICD
via
chemodynamic
therapy
ferroptosis
inductions,
well
antigen
stimulations,
presents
a
better
synergistic
immunopotentiation
action.
Furthermore,
obtained
nanovaccines
achieve
TME‐responsive
magnetic
resonance/photoacoustic
dual‐mode
imaging
contrasts,
while
effectively
inhibiting
primary/distal
growth
metastasis.
Angewandte Chemie International Edition,
Journal Year:
2019,
Volume and Issue:
58(41), P. 14758 - 14763
Published: Aug. 20, 2019
Reactive
oxygen
species
(ROS)
can
be
used
not
only
as
a
therapeutic
agent
for
chemodynamic
therapy
(CDT),
but
also
stimulus
to
activate
release
of
antitumor
drugs,
achieving
enhanced
efficacy
through
the
combination
CDT
and
chemotherapy.
Here
we
report
pH/ROS
dual-responsive
nanomedicine
consisting
β-lapachone
(Lap),
pH-responsive
polymer,
ROS-responsive
polyprodrug.
In
intracellular
acidic
environment,
realize
pH-triggered
disassembly.
The
released
Lap
efficiently
generate
hydrogen
peroxide,
which
will
further
converted
into
highly
toxic
hydroxyl
radicals
via
Fenton
reaction.
Subsequently,
ROS-induced
cleavage
thioketal
linker,
doxorubicin
is
from
vivo
results
indicate
that
cascade
ROS
generation
antitumor-drug
effectively
inhibit
tumor
growth.
This
design
with
reactions
offers
promising
strategy
enhance
efficacy.
Journal of Hematology & Oncology,
Journal Year:
2022,
Volume and Issue:
15(1)
Published: Sept. 12, 2022
Poor
targeting
of
therapeutics
leading
to
severe
adverse
effects
on
normal
tissues
is
considered
one
the
obstacles
in
cancer
therapy.
To
help
overcome
this,
nanoscale
drug
delivery
systems
have
provided
an
alternative
avenue
for
improving
therapeutic
potential
various
agents
and
bioactive
molecules
through
enhanced
permeability
retention
(EPR)
effect.
Nanosystems
with
cancer-targeted
ligands
can
achieve
effective
tumor
cells
utilizing
cell
surface-specific
receptors,
vasculature
antigens
high
accuracy
affinity.
Additionally,
stimuli-responsive
nanoplatforms
also
been
as
a
promising
strategy
against
tumors,
these
maintain
their
stealth
feature
under
conditions,
but
upon
homing
cancerous
lesions
or
microenvironment,
are
responsive
release
cargoes.
In
this
review,
we
comprehensively
summarize
field
active
number
studies
context
emerging
nanoplatform
development,
discuss
how
knowledge
contribute
further
improvements
clinical
practice.